Sunao Fujioka obtained his master's degree in pharmaceutical sciences at the University of Tokyo. He started his career at McKinsey & Company Japan office, then moved to Janssen Pharmaceuticals, and most recently at MSD, mainly in charge of marketing / business operations.
At MSD, he has led launch of the biomarker / diagnostic field in the oncology business, developed and accelerated novel biomarkers / companion diagnostics adoption in Japan market with relevance to immune-checkpoint inhibitors, such as PD-L1, MSI, etc.
University-originated ventures are expected to promote innovation in agriculture, forestry and fisheries.
How agriculture, forestry and fisheries will become in the future?
Or what is necessary to support establishment and stabilization of such ventures?
Let's think about those topics with representatives of university-originated ventures and policy makers.
3F COREDO Muromachi Terrace, 3-2-1 Nihonbashi-Muromachi, Chuo-ku, Tokyo
Muromachi Mitsui Hall, Workshop
November 19, 2019 at 11:00AM - 12:00PM